Cambridge, MA and London,UK – May 26, 2009 -Quanticate, a global biometrics Clinical Research Organization (CRO) today announced it has partnered with Atlantic-Global, a leading provider of integrated business and resource software, to produce a customized, fully web-enabled Project Portfolio Management System.
The combination of Quanticate’s clinical trial and project management capabilities with Atlantic-Global’s Corporate Vision software enables Quanticate to electronically manage its complex global Biometrics program from inception to completion in a single environment. “Quanticate has more than 550 active projects around the world,” said Mark Campbell, Head of Project Management for Quanticate. “The launch of the Corporate Vision software in conjunction with Quanticate’s newly deployed project delivery model places Quanticate at the leading edge of project management best practice, assuring that customers’ individual needs are at the center of each project.”
Through this collaboration, Quanticate and its customers are able to benefit from having a single electronic project management environment with a robust knowledge management repository. “Managing project resources in a single environment that enhance visibility into every level of the project, drives significant benefits to both the Sponsor and Quanticate,” Campbell added. “Working with our customers we are able to predict, monitor and control project performance, and proactively respond to the ever present issues that might otherwise affect project performance.”
To date, Quanticate has deployed multiple modules of the customized system offering strategic and project resource planning, risk and issue management, project financial management, and a report suite to support all project activities.
“We approach project management from a business perspective” said Eugene Blaine, founder and CEO of Atlantic-Global. “We emphasize the need to focus on three key areas within project portfolio management - financial management, resource management and delivery management. Atlantic-Global has partnered with many world leading organizations to ensure that Corporate Vision is both comprehensive and yet easy to use. Atlantic-Global welcomes design contributions from those organizations and values Quanticate’s input into the design of the customer billing and earned value management areas of the solution.“
Visibility into each level of project management is critical, particularly in a tough economic landscape. The customer-centric philosophy of both Quanticate and Atlantic-Global encourages collaboration with customers to fine tune processes and make improvements. “We recognize our customers – and prospects - as individuals with unique requirements, which is why we encourage them to become part of the project management process,” said Campbell. To further that commitment, Quanticate plans on opening up its Project Portfolio Management System to their customers by early fall 2009. This will further advance the value of a shared, single electronic project work space to support resource allocation, risk management, scope and budgets, performance, asset allocation, and more.
Quanticate, with headquarters in Cambridge, MA and London, UK, is the largest global biometrics company with full service clinical trial capabilities. Trusted and respected throughout the industry, Quanticate delivers premium quality clinical trial services, consultancy, highly scalable on-and off-site data management, statistical programming and analysis, and medical writing solutions. Dedicated staff recruitment services are provided through Quanticate People. With resources spanning three continents, Quanticate is renowned for its dedication to customers, world-class service and superior results. In working closely with biotech, pharmaceutical and medical device companies, Quanticate prides itself in being a seamless extension of its customers’ internal teams offering the flexibility to adapt to any technology environment. For more information, visit www.quanticate.com.
Atlantic-Global, founded in 1993, has a rich heritage in the development of pharmaceutical project management software. Its solutions are also supporting projects in such vertical markets as financial services and manufacturing. Its mission is to provide organizations with the tools to understand project costs and timing, accountability and expectations of deliverables. For more information, visit www.atlantic-ec.com/